{"id":"lipofundin-mct","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Infusion site reactions"},{"rate":null,"effect":"Allergic reactions"},{"rate":null,"effect":"Lipemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lipofundin MCT is an intravenous lipid emulsion containing a mixture of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT) designed to supply energy and essential fatty acids to patients unable to receive adequate nutrition orally or enterally. The MCT component is rapidly metabolized and provides quick energy, while the LCT component supplies essential polyunsaturated fatty acids necessary for cellular function and membrane integrity.","oneSentence":"Lipofundin MCT is a lipid emulsion that provides essential fatty acids and calories as a component of parenteral nutrition.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:34:06.667Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition"},{"name":"Provision of essential fatty acids and energy in critically ill or post-operative patients"}]},"trialDetails":[{"nctId":"NCT03282955","phase":"PHASE4","title":"The HOME Study (HPN With OMEGA-3)","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2018-01-08","conditions":"Patients Requiring Home Parenteral Nutrition","enrollment":74},{"nctId":"NCT02578394","phase":"PHASE2, PHASE3","title":"Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study","status":"COMPLETED","sponsor":"Mid and South Essex NHS Foundation Trust","startDate":"2016-04","conditions":"Gout, Chronic Kidney Diseases","enrollment":21},{"nctId":"NCT00497289","phase":"PHASE2","title":"Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2006-01","conditions":"Preterm Infants, Parenteral Nutrition n-3 Fatty Acids","enrollment":48},{"nctId":"NCT04511299","phase":"NA","title":"Impact of Fish Oil-enriched Lipid Emulsion on Fatty Acid and Inflammatory Response in Infants After Surgery","status":"COMPLETED","sponsor":"Dr. Soetomo General Hospital","startDate":"2020-04-07","conditions":"Surgery","enrollment":12},{"nctId":"NCT04347902","phase":"PHASE4","title":"Lipid Emulsions and Liver Function - Results After 5 Years.","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2016-01","conditions":"Liver Failure, Parenteral Nutrition-Related Hepatitis","enrollment":65},{"nctId":"NCT04277923","phase":"PHASE4","title":"Effects of Fat Emulsions on PNALD and Oxidative Stress in Premature Infants","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-02","conditions":"Preterm Infant","enrollment":66},{"nctId":"NCT02633384","phase":"PHASE4","title":"Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions","status":"TERMINATED","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2011-08","conditions":"Intrahepatic, Cholestasis","enrollment":52},{"nctId":"NCT01814956","phase":"PHASE4","title":"Different Lipid Emulsions in Acute Lung Injury Patients","status":"TERMINATED","sponsor":"B. Braun Melsungen AG","startDate":"2013-03","conditions":"Parenteral Nutrition","enrollment":1},{"nctId":"NCT00530738","phase":"PHASE4","title":"Safety and Efficacy of Longterm HPN With Two Lipid Emulsions","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2007-09","conditions":"Malnutrition","enrollment":42},{"nctId":"NCT01745861","phase":"PHASE2","title":"Effects Of Fish Oil Emulsion On Severe Acute Pancreatitis Patients","status":"COMPLETED","sponsor":"University Hospitals, Leicester","startDate":"2010-06","conditions":"Assess Effect of Omega-3 Fish Oil in Patients With Severe Acute Pancreatitis","enrollment":44},{"nctId":"NCT01683162","phase":"PHASE4","title":"Effects of Parenteral Nutrition With Different Lipid Emulsions in Preterm Infants","status":"UNKNOWN","sponsor":"Wei Cai","startDate":"2012-07","conditions":"Preterm Infant","enrollment":150},{"nctId":"NCT00798447","phase":"PHASE3","title":"Efficacy and Safety of a PN Regimen Containing n-3 Fatty Acid in Patients Considered After GI Surgery","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2008-11","conditions":"GI Cancer","enrollment":100},{"nctId":"NCT01025414","phase":"PHASE4","title":"Enteral Nutrition in the Treatment of Pancreatic Fistulas - A Prospective Study","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2006-07","conditions":"Pancreatic Fistula","enrollment":78},{"nctId":"NCT00558155","phase":"PHASE4","title":"The Impact of Immunostimulating Nutrition on the Outcome of Surgery","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2001-06","conditions":"Gastric Cancer, Pancreatic Cancer","enrollment":214}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"TOXIC EPIDERMAL NECROLYSIS"},{"count":3,"reaction":"PRURITUS"},{"count":3,"reaction":"SHOCK"},{"count":3,"reaction":"STEVENS-JOHNSON SYNDROME"},{"count":1,"reaction":"BLISTER"},{"count":1,"reaction":"HYPERTENSION"},{"count":1,"reaction":"LIP ULCERATION"},{"count":1,"reaction":"NEUTROPENIA"},{"count":1,"reaction":"PNEUMONIA"},{"count":1,"reaction":"WRONG TECHNIQUE IN DRUG USAGE PROCESS"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Lipofundin MCT","genericName":"Lipofundin MCT","companyName":"B. Braun Melsungen AG","companyId":"b-braun-melsungen-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lipofundin MCT is a lipid emulsion that provides essential fatty acids and calories as a component of parenteral nutrition. Used for Parenteral nutrition in patients unable to receive adequate oral or enteral nutrition, Provision of essential fatty acids and energy in critically ill or post-operative patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}